Roche acquires Irish biotech firm Inflazome
Swiss pharma company to acquire biotech for $449m (€380m)
Read More
Tag: Inflazome
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
